Even in the antibiotic era, S. aureus remains one of the most feared pathogens with a spectrum of disease ranging from local abscesses to overwhelming sepsis. One of the unique features of S. aureus is its ability to cause metastatic infections. The factors that permit the development of these metastases are not known. We have found that fibronectin binds to S. aureus avidly and specifically and that the number of fibronectin receptors on the strain of S. aureus correlates directly with its invasiveness. Fibronectin is found in abundance at sites of endovascular damage and may serve as an attachment site for S. aureus. Thus, the overall goal of this grant is to characterize the role of fibronectin in the pathogenesis of endovascular, S. aureus infections. We plan to characterize the fibronectin binding factor on S. aureus, to produce antibodies against the fibronectin binding substance on S. aureus, to study the role of fibronectin in the adherence of S. aureus to host tissues in animals using in vitro models of endovascular infection, and to characterize the effects of fibronectin on phagocytosis by endothelial cells and fibroblasts. Because S. aureus infections represent a common and serious threat to patients with artificial or abnormal heart valves; a better understanding of the initiating event, i.e., attachment to tissues, will help to design more rational therapy. The importance of fibronectin in pathogenesis of S. aureus infections will be determined by using fibronectin fragments and antifibronectin antibodies. If S. aureus attachment to fibronectin proves important in the initiation of S. aureus infections, then antibodies directed at the fibronectin receptor on S. aureus may be able to prevent these infections. This suggests the possibility of a vaccine. We plan to isolate the fibronectin receptor on S. aureus by fibronectin-Sepharose affinity, by QAE, and gel-filtration chromatography. We will study attachment of S. aureus in vitro by testing adherence of S. aureus to clots, subendothelial matrices, collagen-fibronectin matrices, endothelial cells, and fibroblasts. Use of fibronectin fragments and antibodies to the fibronectin receptor will provide specificity for the S. aureus-fibronectin interactions. Finally, ultrastructural and histochemical studies of S. aureus interactions with fibronectin and host cells will be performed.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI016881-06
Application #
3126883
Study Section
Bacteriology and Mycology Subcommittee 1 (BM)
Project Start
1981-09-30
Project End
1989-06-30
Budget Start
1988-07-01
Budget End
1989-06-30
Support Year
6
Fiscal Year
1988
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Vaudaux, P; Pittet, D; Haeberli, A et al. (1993) Fibronectin is more active than fibrin or fibrinogen in promoting Staphylococcus aureus adherence to inserted intravascular catheters. J Infect Dis 167:633-41
Proctor, R A (1992) The use of selective mutagenesis to study the pathogenesis of gram-positive bacterial diseases. J Lab Clin Med 119:5-10
Vaudaux, P; Yasuda, H; Velazco, M I et al. (1990) Role of host and bacterial factors in modulating staphylococcal adhesion to implanted polymer surfaces. J Biomater Appl 5:134-53
Vann, J M; Hamill, R J; Albrecht, R M et al. (1989) Immunoelectron microscopic localization of fibronectin in adherence of Staphylococcus aureus to cultured bovine endothelial cells. J Infect Dis 160:538-42
Kuypers, J M; Proctor, R A (1989) Reduced adherence to traumatized rat heart valves by a low-fibronectin-binding mutant of Staphylococcus aureus. Infect Immun 57:2306-12
Vann, J M; Proctor, R A (1988) Cytotoxic effects of ingested Staphylococcus aureus on bovine endothelial cells: role of S. aureus alpha-hemolysin. Microb Pathog 4:443-53
Vann, J M; Proctor, R A (1987) Ingestion of Staphylococcus aureus by bovine endothelial cells results in time- and inoculum-dependent damage to endothelial cell monolayers. Infect Immun 55:2155-63
Proctor, R A (1987) Fibronectin: a brief overview of its structure, function, and physiology. Rev Infect Dis 9 Suppl 4:S317-21
Proctor, R A (1987) Fibronectin: an enhancer of phagocyte function. Rev Infect Dis 9 Suppl 4:S412-9
Proctor, R A (1987) The staphylococcal fibronectin receptor: evidence for its importance in invasive infections. Rev Infect Dis 9 Suppl 4:S335-40

Showing the most recent 10 out of 12 publications